Mario Delgado, PhD, received his PhD in biological sciences in 1996 from the Complutense University Madrid, where he obtained a position as associate professor. In 2003, he moved to the Institute of Parasitology and Biomedicine in Granada, Spain, where he is full professor and director of the institute. As a neuroimmunologist, he is focused on understanding the bidirectional communication between immune and neuroendocrine systems. A primary objective of his research is to identify endogenous anti-inflammatory factors, mainly neuropeptides and hormones, with the aim of designing new therapeutic strategies for immune and neurodegenerative disorders. Moreover, he discovered the immunomodulatory actions of adipose-derived mesenchymal stem cells.

Dr. Delgado is the author of 180 publications in the field of neuroimmunology (>11500 cites, H-index 61 in WoS, cumulative impact factor>1000). He has licensed three patents for the treatment of inflammatory disorders with neuropeptide- and stem cell-based therapies, which were translated in many clinical trials and a commercial medicament (Alofisel).